Search results for "Diabetes"
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016
EHRs may improve diabetes management and achievement of treatment goals, particularly among those with worst disease control
Use of a commercially available electronic health record (EHR) was associated with improved care processes and better achievement of intermediate treatment outcomes for outpatients with diabetes, a study found.
https://immattersacp.org/weekly/archives/2012/10/02/1.htm
2 Oct 2012
No reason for higher HbA1c threshold to diagnose diabetes in blacks
Retinopathy occurs at lower hemoglobin A1c (HbA1c) levels in blacks than in whites, so there is no reason to recommend a higher HbA1c threshold for diagnosing diabetes in blacks, a study concluded.
https://immattersacp.org/weekly/archives/2012/08/07/1.htm
7 Aug 2012
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://immattersacp.org/weekly/archives/2022/11/08/4.htm
8 Nov 2022
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024
Type of insulin may affect hypoglycemia rates in older adults with type 2 diabetes, study finds
Risk may be lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin.
https://immattersacp.org/weekly/archives/2021/03/09/4.htm
9 Mar 2021
Registration open for ACP webinars on diabetes, opioids, and gender equity
Topics include “Update on Diabetes Mellitus,” “Managing Patients Not Benefiting From (or Being Harmed by) Opioids,” and “Putting Gender Equity Principles into Action.”
https://immattersacp.org/weekly/archives/2018/08/28/6.htm
28 Aug 2018
Decision support intervention for clinicians helped decrease low-value care
A tool to increase clinicians' attention to the possible harms of overtreatment among older adults, among other aims, was associated with a greater decline in prostate-specific antigen testing, unspecified urine testing, and diabetes overtreatment compared with an education-only approach.
https://immattersacp.org/weekly/archives/2024/02/06/4.htm
6 Feb 2024
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/12/06/3.htm
6 Dec 2022
Targeting social needs may help improve type 2 diabetes outcomes, review finds
A systematic review found that HbA1c levels were improved significantly by food supplementation with referral and diabetes support, financial incentives with education and skills training, housing relocation with counseling support, and the integration of nonmedical interventions into medical care.
https://immattersacp.org/weekly/archives/2022/07/05/3.htm
5 Jul 2022